Dassault Systèmes has launched ‘Licensed to Cure’, an industry solution experience for medical device manufacturers which is designed to help accelerate the delivery of innovative, safe and fully compliant medical devices. Based on the 3DEXPERIENCE platform, it ensures a single source of information for innovation, and a fully-transparent and fully-documented change process, allowing manufacturers to optimise resource allocation, maximise IP reuse, and streamline the regulatory filing process. By creating an end-to-end, traceable and compliant product development process, medical device manufacturers can expedite time to market and minimise regulatory overhead.
Monica Menghini, Dassault Systèmes, said: “Our 3DEXPERIENCE platform, with dedicated industry solution experiences, enables companies to manage their business objectives in a complex regulatory environment while meeting consumers’ expectations for safe products.”
